Launch Timeline: From Idea to First 1,000 Bottles

A gummy supplement brand is not a kitchen project you scale up. It is a regulated product made by a third party, sold mostly through Amazon and a direct-to-consumer store, and made profitable by repeat purchases. The plan below maps the work in the order a founder actually does it, because lenders and contract manufacturers both want to see that you understand the sequence before you ask for money or a production slot.

Months 1-2 - Niche and formulation

Pick a single buyer before you pick a flavor. A women's hair-and-nails biotin gummy, a children's multivitamin, a sleep gummy with melatonin, and an apple cider vinegar gummy are four completely different businesses with different claims, different repeat rates, and different shelf competitors. Brief two or three contract manufacturers on the concept and request stock-formula samples. This is where Goli built its entire company on a single apple cider vinegar SKU before expanding.

Months 2-4 - Manufacturer, testing and label

Lock a manufacturer, agree the minimum order quantity, and pay for a sample production run. While that batch is being made, commission third-party testing for potency, microbial safety and heavy metals, and finalise a compliant Supplement Facts panel. Budget $1,000-$3,000 per SKU for testing alone; skipping it is the single most common reason a brand fails an Amazon or retailer audit later.

Months 4-6 - Storefront and pre-launch list

Build the Shopify or WooCommerce store, set up an Amazon Seller Central account, and start collecting emails before product lands. A pre-launch waitlist of even 500 people turns a cold launch into day-one revenue and gives the financial model a real first-month number instead of a guess.

Months 6-12 - Acquisition and subscription

The first sale rarely pays back paid advertising in this category. The plan should show the month the subscription base becomes large enough that recurring contribution covers acquisition spend. Most brands that survive reach that crossover somewhere between month 9 and month 14, which is exactly the window a lender will scrutinise.

What It Costs to Launch a Gummy Vitamin Brand

Most "how to start" articles dodge the number. The honest range for a private-label launch with one to three SKUs is $12,000 to $120,000 (about £9,000 to £95,000). The spread is wide because it is driven almost entirely by your first production run, which is set by minimum order quantity and whether you use a stock formula or a custom one. There is one cost everyone overestimates: FDA facility registration, which is free.

Cost breakdown

• First production run (1,000-5,000 bottles, private label): $4,000-$60,000 (£3,200-£48,000)
• Formulation / custom flavor development: $2,000-$15,000 (£1,600-£12,000)
• Third-party testing (potency, microbial, heavy metals) per SKU: $1,000-$3,000 (£800-£2,400)
• Brand identity and compliant label artwork: $1,500-$8,000 (£1,200-£6,400)
• Amazon / DTC store build and launch marketing: $3,000-$30,000 (£2,400-£24,000)
• FDA facility registration (US) / FBO registration (UK): free

Funding routes that fit this business

In the US, an SBA 7(a) loan (up to $5M, though gummy brands rarely ask for more than $50K-$150K at launch) and SBA microloans (up to $50,000 through non-profit intermediaries) suit inventory-heavy consumer goods. Equipment financing is mostly irrelevant unless you are self-manufacturing. In the UK, the government-backed Start Up Loan (up to £25,000 per founder at 6% fixed, so a two-founder team can stack £50,000) is the most common first cheque, frequently topped up by an angel or an SEIS raise that gives investors generous tax relief. Crowdfunding on Kickstarter or Crowdcube works in this category precisely because a gummy is a tangible, photogenic product that pre-sells well. Whatever the route, every lender and platform wants the same artefact: a plan with a credible repeat-purchase forecast, which is what the bespoke plan is built to deliver.

Choosing a Contract Manufacturer (and Three Models)

For roughly 99% of new brands, a contract manufacturer is the only realistic path to market. Building your own 21 CFR Part 111 facility costs hundreds of thousands of dollars and makes no sense until you are moving serious volume. The plan should name the shortlist, the MOQ each one quotes, and which certifications they hold, because a co-manufacturer without NSF or third-party cGMP certification will eventually block you from a major retailer.

Named US contract manufacturers founders shortlist

• Matsun Nutrition - low minimums (from around 2,500 units), strong for first-time founders testing a stock formula.
• SMP Nutra - broad private-label gummy catalogue, fast turnaround, low-MOQ stock SKUs.
• Makers Nutrition - full-service from formulation to fulfilment, good when you want one vendor end to end.
• Vitajoy USA - pectin-based and vegan gummy specialist, useful for plant-based positioning.
• Gummi World - established gummy-only manufacturer for higher-volume custom runs.
• Pharmavite - the contract scale behind mass-market brands; relevant once you are past six figures of annual volume.

Ask each one three questions before anything else: what is the MOQ for a stock versus a custom formula, do they hold current 21 CFR 111 or NSF certification, and will they provide a Certificate of Analysis per batch. Anyone evasive on the third question should come off the list.

Three operating models - and what changes

Most plans we write start a brand in column one or two and treat column three as a year-three milestone tied to a specific volume threshold, not a launch decision.

What a manufacturer needs from you

Founders often arrive at a manufacturer expecting to be sold to, then discover the manufacturer is screening them just as hard. A good co-manufacturer wants to see that you have chosen a niche, that you understand the claims you can and cannot make, and that you have the working capital to reorder before the first run sells through. Arriving with a clear brief - target buyer, desired actives and dose, pectin or gelatin base, bottle count, and target landed cost - shortens the timeline and earns you better terms. Arriving with "I want to sell gummies" marks you as a tourist, and the best manufacturers quietly deprioritise tourists.

Lead times are the other number to pin down in writing. A stock formula can ship in four to six weeks; a custom formula with stability testing can take three to four months from brief to finished pallet. Your launch timeline and your cash forecast both depend on that figure, so the plan should quote the manufacturer's actual lead time, not an optimistic guess. Reorder lead time matters even more once you are live: run out of stock on Amazon and you lose the search ranking you paid to build, which is far more expensive than the inventory itself.

FDA, FSA & Global Compliance

Gummy vitamins are dietary supplements, not food novelties and not drugs. That single classification decides almost every rule that follows. The mistake that ends brands is not missing a licence; it is making a claim that crosses from "supports" into "treats", which turns a supplement into an unapproved drug in the eyes of regulators.

United States

• FDA Food Facility Registration - register your facility (or confirm your co-manufacturer's registration) under Section 415 of the FD&C Act via the FFRM system. Free, renewed every two years. FDA cGMP guidance, 2026
• 21 CFR Part 111 cGMP - the dietary-supplement good-manufacturing-practice rule. A compliant contract manufacturer carries most of this for you; a master manufacturing record is required per SKU. eCFR 21 CFR Part 111
• Supplement Facts panel + DSHEA structure/function claims - use the correct panel format, carry the "This statement has not been evaluated by the FDA…" disclaimer, and notify the FDA within 30 days of first marketing a structure/function claim.
• FTC advertising rules - every claim in your marketing must be substantiated; the FTC, not just the FDA, polices supplement advertising.

United Kingdom

• Food Supplements (England) Regulations 2003 (and equivalents in Scotland, Wales and Northern Ireland) govern what counts as a food supplement and how it is presented. FSA, Food supplements
• Permitted vitamin and mineral lists - only the forms in Schedules I and II of The Nutrition (Amendment etc) (EU Exit) Regulations 2019 may be used.
• Food Business Operator (FBO) registration - register with your local authority at least 28 days before you start trading. Free.
• Health-claim and novel-food checks - any health claim must appear on the GB Nutrition and Health Claims register; an ingredient with no significant pre-May-1997 consumption history needs authorisation under Novel Foods Regulation 2015/2283, a process that can take one to two years.

Other jurisdictions

• Canada: gummy vitamins are Natural Health Products. You need a Natural Product Number (NPN) and a site licence from Health Canada before any sale.
• European Union: notify each member state's competent authority, use only EFSA-permitted nutrient forms, and stick to authorised health claims; rules vary country by country despite the shared framework.

Unit Economics & the Subscription Math That Decides It

This is the section most guides skip and the one lenders read first. A gummy vitamin sells for $20-$35 a bottle direct-to-consumer. Landed cost of goods at a low MOQ sits around $4-$8 a bottle once you include the gummy, bottle, label, and inbound freight. That looks like a luxurious 60-75% gross margin, and at the gross line it is. The problem lives below.

A worked example

Take a $28 bottle with a $6 landed cost. Contribution before marketing is $22. On Amazon, a roughly 15% referral fee plus FBA fulfilment knocks $6-$8 off that, leaving $14-$16. If paid acquisition costs you $20-$30 to win a customer, the first order loses money. The business only works if that customer subscribes. At a $22 DTC contribution and 8% monthly churn, an average subscriber stays about 12 months and delivers roughly $260 of lifetime contribution. Against a $25 acquisition cost, that is a 10x return - but only after month one. The plan has to show the cash gap in between, which is exactly why the funding ask exists.

Revenue streams worth modelling

• Subscription DTC: the profit engine - recurring 30-day deliveries at the highest margin and lowest repeat-acquisition cost.
• Amazon / marketplace: volume and discovery, but the platform takes its cut and owns the customer relationship.
• Retail and wholesale: credibility and reach at roughly half the margin; useful once the brand is proven.
• Bundles and multi-SKU baskets: the cheapest way to lift average order value once a buyer trusts you.

Per-unit cost also depends heavily on order size. Stock product runs $4-$16 a unit and custom formulations $5-$30, with higher MOQs cutting the per-unit number and lifting margin. A plan that models only one MOQ is hiding its most important sensitivity.

The cash gap nobody mentions

There is a structural cash trap in this business that a forecast must surface. You pay the manufacturer for a full production run upfront, then sell it through over months, then have to reorder before the previous run is fully sold so you never stock out. That means inventory cash is always ahead of revenue cash, and a brand that is growing on paper can run out of money in the bank. The faster you grow, the worse the squeeze, because each reorder is larger than the last. This is the single most common reason healthy-looking gummy brands stall, and it is exactly why the funding ask is sized to cover two to three production cycles, not just the first one. A plan that funds only the opening run is funding a stockout.

The flip side is that subscription smooths the demand signal. Once a meaningful share of revenue is recurring, you can forecast reorder timing with far more confidence, which lets you negotiate better payment terms with the manufacturer and hold less safety stock. That is another reason the subscription is not just a marketing preference but a balance-sheet decision.

Market Size & Who Is Actually Buying

The global gummy supplements market was worth roughly $11.75B in 2025 and is forecast to grow at about 12.96% a year, reaching an estimated $35.56B by 2034 Fortune Business Insights, 2025. Narrower definitions that count only vitamin gummies are smaller and slower - Fact.MR puts that slice on a 5.1% path to $7.18B by 2034 Fact.MR via GlobeNewswire, 2024. The gap between those numbers matters: a plan that quotes the biggest figure without saying which definition it uses will be marked down by any analyst who knows the category.

Who buys gummy vitamins

The category grew because gummies solve a behavioural problem, not a nutritional one: people who hate swallowing pills take a gummy. That puts the core buyer among adults seeking everyday wellness, parents buying children's multivitamins, and a fast-growing segment of buyers chasing a specific outcome - sleep, beauty, immunity, gut health. The clearest signal of how hot the category runs came in April 2026, when Unilever acquired the supplement brand Grüns, a reminder that the consumer giants now see gummy-format wellness as core, not fringe.

For a new brand the implication is sharp: you will not out-spend OLLY, SmartyPants or Vitafusion on shelf, so the plan must define a buyer narrow enough that those giants are not optimising for them. A women's postnatal gummy, a teen-specific multivitamin, or a halal-certified line each carve out space the mass brands under-serve.

Target Buyer & Competitive Positioning

The competitive map for gummy vitamins has three layers, and a credible plan addresses all three rather than pretending the only rivals are other small brands. At the top sit the mass incumbents - OLLY (San Francisco, founded 2013), SmartyPants (Los Angeles, 2011), Vitafusion under Church & Dwight (Ewing, New Jersey), and Garden of Life. They own shelf space, retail relationships, and advertising budgets a startup cannot match. In the middle sit direct-to-consumer challengers like Goli Nutrition, which proved a single apple cider vinegar SKU could scale through social media before retail caught up. At the bottom sits the long tail of private-label brands, many indistinguishable from each other, competing on price and packaging.

A new entrant cannot win the top layer head-on, so the plan has to define a buyer narrow enough that the incumbents are not optimising for them. That is where defensible positions live: a postnatal gummy formulated for new mothers, a teen-specific multivitamin sold to parents of older children, a halal- or kosher-certified line, a sugar-free range for diabetic-aware buyers, or a single-outcome product such as a sleep gummy with a clean melatonin dose. Each of these is a segment the mass brands treat as a footnote, which is exactly what makes it winnable.

The point of the table is not decoration. Each segment has a different repeat rate, a different acceptable acquisition cost, and a different competitive set, and the financial model should reflect whichever one you lead with. A plan that lists every possible buyer is a plan that has chosen none of them, and lenders read that as a founder who has not yet found the business.

Marketing & the Subscription Engine

Acquisition and retention are not two marketing tactics in this category; they are the whole business model. Because the first order frequently loses money after acquisition cost, the marketing plan has to be written backwards from the subscription, not forwards from a launch campaign.

Where first customers come from

Most gummy brands open on two channels. Amazon delivers volume and discovery but takes roughly 15% plus fulfilment and owns the customer relationship, so it is a way to find buyers rather than keep them. A direct-to-consumer store on Shopify or WooCommerce gives lower reach but full control of pricing, data, and the subscription offer. The pragmatic sequence is to use Amazon and paid social to find buyers, then move the relationship onto the owned store through inserts, email, and a better subscribe-and-save price.

The content that compounds

Paid acquisition is rented; content and reviews are owned. Brands that survive build a steady stream of reviews, user-generated content, and search-friendly answers to the exact questions buyers ask before purchase. Goli's rise was as much about ubiquitous social content as it was about the product itself. The plan should budget for content production as a line item, not treat it as a free by-product of the founder's time.

Modelling the engine

A serious marketing section ties three numbers together: cost to acquire a customer (CAC), the share of customers who convert to subscription, and monthly churn. Move any one of those and the whole forecast moves. A brand acquiring at $25 with a 40% subscription take-rate and 8% monthly churn is healthy; the same brand at $35 CAC with a 20% take-rate and 12% churn is quietly insolvent. Showing those sensitivities is what separates a plan a lender funds from one they decline.

• Awareness: Amazon search, paid social, and reviews capture buyers at the moment of intent.
• First conversion: a sharp landing page, honest claims, and a subscribe-and-save offer reduce friction.
• Retention: the 30-day subscription, email flows, and bundles turn one purchase into lifetime value.
• Referral: a tangible, photogenic product makes word-of-mouth and affiliate programmes unusually effective.

More Questions Founders Ask

Do I need FDA approval before I can sell?

No. The FDA does not pre-approve dietary supplements. You register the facility, follow 21 CFR Part 111, label correctly, and stay inside structure/function claims. Approval is a myth that costs founders weeks of confusion.

What is a realistic minimum order quantity?

Stock formulas can start at 500-1,000 bottles with manufacturers like Matsun Nutrition; most co-manufacturers sit at 2,500-5,000 bottles; custom formulas push the floor to 8,000-16,000 bottles because of minimum batch sizes. Your first run should be the smallest number that still gives a sane per-unit cost.

Can I make gummy vitamins at home and sell them?

Not for retail. The cGMP and per-batch testing requirements cannot be met in a home kitchen, which is why nearly every brand contracts production out.

How do I compete with OLLY and Goli on Amazon?

You do not compete head-on. You win a sub-segment they treat as a footnote, build a subscription base that does not depend on Amazon search, and use reviews and content to defend it. Goli itself proved a single focused SKU can outrun incumbents before they react.

Is a subscription really necessary?

For profitability, yes. With first-order economics that often lose money after acquisition cost, the recurring 30-day order is what turns a customer into profit. A plan without a subscription forecast is a plan that has not found where the money is.

Five Mistakes That Sink Gummy Brands

• Selling it as a one-time purchase. The category's profit lives in subscription. Building the whole funnel around single bottles guarantees you spend more to acquire than you earn.
• Skipping testing to save $1,000-$3,000. Potency, microbial and heavy-metal testing per batch is non-negotiable. The brands that cut it fail a retailer or Amazon audit at the worst possible moment.
• Drifting into disease claims. "Supports immune health" is fine; "prevents colds" turns your supplement into an unapproved drug and invites an FDA warning letter.
• Chasing the lowest MOQ without checking certification. A cheap co-manufacturer with no 21 CFR 111 or NSF credentials will block you from the retailers you eventually want.
• Under-pricing. A $20 retail price on an $8 landed cost cannot fund paid acquisition in this category. Price for the marketing you will actually need.

Terms Every Gummy Founder Should Know

Contract manufacturers and lenders both use a shorthand that trips up first-time founders. Get these straight before your first call.

• MOQ (Minimum Order Quantity): the smallest production run a manufacturer will accept. Lower MOQ means lower upfront cash but higher per-unit cost.
• cGMP / 21 CFR Part 111: the US good-manufacturing-practice rules specific to dietary supplements. A compliant co-manufacturer carries most of this for you.
• Supplement Facts panel: the FDA-mandated label format for dietary supplements, distinct from the Nutrition Facts panel used on food.
• Structure/function claim: a statement like "supports immune health" that is allowed with a disclaimer, as opposed to a disease claim, which is not.
• Certificate of Analysis (CoA): the per-batch document proving your gummies were tested for potency, microbes, and heavy metals.
• Pectin vs gelatin: the two base systems for a gummy. Pectin is plant-based and supports vegan positioning; gelatin is animal-derived and cheaper.
• Subscribe-and-save: the recurring-order offer, usually at a small discount, that converts a one-time buyer into the subscription base where profit lives.
• CAC and LTV: cost to acquire a customer and the lifetime value that customer delivers. The ratio between them is the number a lender checks first.

Sample Business Plan Preview

Here is the structure and the financial output a buyer receives. These mockups use the same assumptions referenced throughout this page so the numbers tie back to the unit economics above.

What's in the Template

Every Avvale business plan template includes these sections, pre-structured for a gummy supplement brand:

• Executive Summary - your brand at a glance, written to hook a lender or investor in 60 seconds
• Company Overview - legal structure, ownership, and the niche you have chosen to own
• Industry Analysis - gummy supplement market size, growth, and the regulatory frame
• Customer Analysis - the specific buyer, their trigger, and why they subscribe
• Competitor Analysis - where OLLY, SmartyPants, Goli and Vitafusion sit and the gap you fill
• Marketing Plan - Amazon, DTC, and the subscription engine that drives repeat revenue
• Operations Plan - manufacturer selection, MOQ, testing, fulfilment, and key milestones
• Management Team - founder background, advisers, and the hires the plan funds

The optional Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with income statement, cash flow, balance sheet, break-even analysis, subscriber cohort modelling, and the startup capital requirement.

Working on an adjacent product? See our industry-specific template, browse all free business plan templates, or read related Avvale case studies.

Frequently Asked Questions

Useful Links & Resources

These links were preserved from the live page so important references and partner links are not lost during the page refresh.

• Facebook
• Instagram
• LinkedIn
• YouTube